Array BioPharma To Present At The Cantor Fitzgerald 2015 Healthcare Conference

Loading...
Loading...

BOULDER, Colo., July 6, 2015 /PRNewswire/ -- Array BioPharma Inc. ARRY today announced that its Chief Executive Officer, Ron Squarer, will present at the Cantor Fitzgerald 2015 Healthcare Conference in New York City.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

 

Event:

Cantor Fitzgerald 2015 Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer

Date:

Wednesday, July 8, 2015

Time:

1:00 p.m. Eastern Time

Webcast:

www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Six Phase 3 studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca).  For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-cantor-fitzgerald-2015-healthcare-conference-300109222.html

SOURCE Array BioPharma Inc.

Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...